WHO says it awaits full data from Merck on antiviral pill

This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEH9B0E9_L.jpg

WHO spokesperson Christian Lindmeier, asked at a U.N. briefing in Geneva about the drug, said: “Indeed, this is an interesting development. We would have to see the full data about it. If it holds true, then it is another weapon in the fight against the COVID-19 pandemic.”

The treatment, molnupiravir, cut the rate of hospitalisation and death by 50% in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to data released this month.

Add Comment